| 0 |
HEPATIC FIBROSIS MARKER INCREASED |
1 |
0.0333 |
| 1 |
COAGULATION FACTOR V LEVEL ABNORMAL |
1 |
0.0081 |
| 2 |
PARANEOPLASTIC PEMPHIGUS |
1 |
0.0077 |
| 3 |
OROPHARYNGEAL ERYTHEMA |
1 |
0.0068 |
| 4 |
STAPHYLOCOCCAL SCALDED SKIN SYNDROME |
1 |
0.0044 |
| 5 |
CARDIAC DEATH |
3 |
0.0025 |
| 6 |
PYURIA |
1 |
0.0010 |
| 7 |
VULVOVAGINAL CANDIDIASIS |
1 |
0.0007 |
| 8 |
GENITAL PAIN |
1 |
0.0007 |
| 9 |
ANTIPHOSPHOLIPID SYNDROME |
1 |
0.0006 |
| 10 |
LINEAR IGA DISEASE |
1 |
0.0006 |
| 11 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 12 |
LIP PAIN |
1 |
0.0003 |
| 13 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 14 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 15 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 16 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 17 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 18 |
APHTHOUS ULCER |
1 |
0.0001 |
| 19 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 20 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 21 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 22 |
LUPUS-LIKE SYNDROME |
1 |
0.0001 |
| 23 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 24 |
RENAL PAIN |
1 |
0.0001 |
| 25 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 26 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 27 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 28 |
SINUS CONGESTION |
1 |
0.0001 |
| 29 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 30 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 31 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 32 |
DRUG ERUPTION |
1 |
0.0001 |
| 33 |
FOOT FRACTURE |
1 |
0.0001 |
| 34 |
FEELING JITTERY |
1 |
0.0001 |
| 35 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 36 |
TASTE DISORDER |
1 |
0.0000 |
| 37 |
DERMATITIS |
1 |
0.0000 |
| 38 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 39 |
ORAL PAIN |
1 |
0.0000 |
| 40 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 41 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 42 |
ANGINA PECTORIS |
1 |
0.0000 |
| 43 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 44 |
HOSPITALISATION |
5 |
0.0000 |
| 45 |
NIGHT SWEATS |
1 |
0.0000 |
| 46 |
SKIN DISORDER |
1 |
0.0000 |
| 47 |
EYE PRURITUS |
1 |
0.0000 |
| 48 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 49 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 50 |
DYSURIA |
1 |
0.0000 |
| 51 |
HOT FLUSH |
2 |
0.0000 |
| 52 |
DYSKINESIA |
1 |
0.0000 |
| 53 |
POLLAKIURIA |
1 |
0.0000 |
| 54 |
MENTAL DISORDER |
1 |
0.0000 |
| 55 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 56 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 57 |
TINNITUS |
1 |
0.0000 |
| 58 |
HYPOKALAEMIA |
1 |
0.0000 |
| 59 |
RENAL DISORDER |
1 |
0.0000 |
| 60 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 61 |
ECZEMA |
1 |
0.0000 |
| 62 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 63 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 64 |
DEPRESSED MOOD |
1 |
0.0000 |
| 65 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 66 |
OEDEMA |
1 |
0.0000 |
| 67 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 68 |
MYALGIA |
3 |
0.0000 |
| 69 |
FLATULENCE |
1 |
0.0000 |
| 70 |
DYSPHONIA |
1 |
0.0000 |
| 71 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |
| 72 |
DISCOMFORT |
1 |
0.0000 |
| 73 |
MUSCLE SPASMS |
3 |
0.0000 |
| 74 |
FEELING HOT |
1 |
0.0000 |
| 75 |
RHINORRHOEA |
1 |
0.0000 |
| 76 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 77 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 78 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 79 |
CONSTIPATION |
3 |
0.0000 |
| 80 |
BRONCHITIS |
1 |
0.0000 |
| 81 |
EPISTAXIS |
1 |
0.0000 |
| 82 |
HALLUCINATION |
1 |
0.0000 |
| 83 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 84 |
PRURITUS |
5 |
0.0000 |
| 85 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 86 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 87 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 88 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 89 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 90 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 91 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 92 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 93 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 94 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 95 |
HEADACHE |
6 |
0.0000 |
| 96 |
FALL |
3 |
0.0000 |
| 97 |
WEIGHT INCREASED |
2 |
0.0000 |
| 98 |
ASTHMA |
1 |
0.0000 |
| 99 |
DYSPNOEA |
5 |
0.0000 |
| 100 |
CHILLS |
1 |
0.0000 |
| 101 |
FEELING ABNORMAL |
2 |
0.0000 |
| 102 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 103 |
ARTHRALGIA |
3 |
0.0000 |
| 104 |
WEIGHT DECREASED |
2 |
0.0000 |
| 105 |
RASH |
3 |
0.0000 |
| 106 |
MALAISE |
3 |
0.0000 |
| 107 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 108 |
HYPOAESTHESIA |
1 |
0.0000 |
| 109 |
PAIN |
4 |
0.0000 |
| 110 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 111 |
PARAESTHESIA |
1 |
0.0000 |
| 112 |
DRUG INTERACTION |
1 |
0.0000 |
| 113 |
TREMOR |
1 |
0.0000 |
| 114 |
DIZZINESS |
3 |
0.0000 |
| 115 |
DEATH |
5 |
0.0000 |
| 116 |
COVID-19 |
1 |
0.0000 |
| 117 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 118 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 119 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 120 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 121 |
DECREASED APPETITE |
1 |
0.0000 |
| 122 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 123 |
FATIGUE |
3 |
0.0000 |
| 124 |
COUGH |
1 |
0.0000 |
| 125 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 126 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 127 |
DIARRHOEA |
2 |
0.0000 |
| 128 |
PNEUMONIA |
1 |
0.0000 |
| 129 |
PYREXIA |
1 |
0.0000 |
| 130 |
ASTHENIA |
1 |
0.0000 |
| 131 |
VOMITING |
1 |
0.0000 |
| 132 |
NAUSEA |
1 |
0.0000 |
| 133 |
OFF LABEL USE |
1 |
0.0000 |
| 134 |
DRUG INEFFECTIVE |
1 |
0.0000 |